Abiopharma

🔍 Kowalski Jessica Patricia (Executive)

Company: JOHN WILEY & SONS, INC. (WLY, WLYB)

Report Date: 2026-05-11

Detailed Transactions and Holdings:

• Acquired 36,792 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 36,792.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: 1-for-1
• F2: On May 11, 2026, the reporting person was granted 36,792 restricted stock units. The restricted stock units vest in three annual installments of 10%, 80%, and 10% of the total award on the first, second, and third anniversaries of the grant date, respectively. Restricted stock units are subject to forfeiture under the terms and conditions of the grant.